Skip to content
← Back to this collection

PUBLICATIONS · 11157041

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2001 Feb 1
First author
Kushner BH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kushner BH
      type
      Author
    2. name
      Meyers PA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kushner BH
      type
      Author
    2. name
      Meyers PA
      type
      Author
    bibliography ids
    1. nci-bib-2695801d11a66001c800d685
    book metadata
    content sha256
    fe6b446ba04492005d4d5bf4df3452c843cc9946d1fc4210d4d63c3225fdea7e
    document type
    citation
    dois
    1. 10.1200/JCO.2001.19.3.870
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11157041
    immutable id
    pubmed:11157041@fe6b446ba04492005d4d5bf4df3452c843cc9946d1fc4210d4d63c3225fdea7e
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    3
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    870-80
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11157041
      provenance
      batch id
      30d2cd7affbbb92b6784
      provider
      NCBI PubMed ESummary
      record sha256
      bb124092859f8f9cf66dc6662673e74b4180cb0b211ff115262f2d772ed43c95
      response sha256
      ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
      retrieved at
      2026-09-09T23:45:39.779418+00:00
      publication date
      display
      2001 Feb 1
      precision
      day
      year
      2001
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      3. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11157041/
      title
      How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.

      Preserved source evidence · Not medical advice